Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?

Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?

Lung cancer is the leading cause of cancer-related mortality and will affect ~6% of the population. It is divided into two broad categories, small cell lung cancer and non-small cell lung cancer (NSCLC), the latter representing 85% of all lung cancers. It mainly comprises adenocarcinoma (65%) and sq...

Full description

Bibliographic Details
Main Authors: Alex Friedlaender, Giuseppe Banna, Umberto Malapelle, Pasquale Pisapia, Alfredo Addeo
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Oncology
Subjects:
NGS—next generation sequencing
squamous cell lung cancer (SQCLC)
targeted therapy (TT)
FGFR1 amplification
PI3 K
non-small cell lung cancer
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00166/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00166/full

Similar Items